A qualitative study of perceived barriers to hepatitis C care among people who did not attend appointments in the non-urban US South
- PMID: 32948189
- PMCID: PMC7501689
- DOI: 10.1186/s12954-020-00409-9
A qualitative study of perceived barriers to hepatitis C care among people who did not attend appointments in the non-urban US South
Abstract
Background: Most people diagnosed with hepatitis C virus (HCV) have not linked to care, despite the availability of safe and effective treatment. We aimed to understand why people diagnosed with HCV have not pursued care in the non-urban Southern United States.
Methods: We conducted a survey and semi-structured interview with participants referred to an HCV clinic who did not attend an appointment between 2014 and 2018. Our clinic is located in a non-urban region of Virginia at a university hospital. Qualitative data collection was guided by the Health Belief Model (HBM). Data was analyzed using qualitative content analysis to identify key factors influencing patient perceptions regarding HCV and pursuit of care.
Results: Over half of previously referred patients (N = 200) could not be reached by phone. Eleven participants enrolled, including 7 men and 4 women. Based on survey responses, unreliable transportation, unstable housing, substance use, and lack of insurance were common. Participants demonstrated good knowledge of HCV disease, complications, and treatment. On qualitative analysis of semi-structured interviews, final themes emerged from within and between HBM constructs. Emerging themes influencing patient perceptions included (1) structural barriers, (2) stigma, (3) prior experiences of HCV disease and treatment, (4) discordance between the recognized severity of HCV and expected impacts on one's own health, and (5) patient-provider relationship. Substance use was not identified to be a barrier to care.
Conclusions: Participants perceived individual and structural barriers to linking to care. A strong HCV knowledge base was not sufficient to motivate pursuit of care. Efforts to improve linkage to care must address barriers at multiple levels, and system-level changes are needed. As the majority of previously referred patients could not be contacted by phone, current approaches to patient engagement are not effective for reaching these populations. Expansion of HCV care to primary care settings with an established patient-provider relationship or co-located treatment within substance use treatment programs may serve to increase access to HCV treatment.
Keywords: Content analysis; Health Belief Model; Hepatitis C; Linkage to care; Stigma; Substance use.
Conflict of interest statement
KAM reports stock ownership in Gilead Sciences, Inc. RD provides consulting services for Warm Health Technologies, an mHealth company. RD and KAM are recipients of an investigator-initiated grant from Gilead Sciences, Inc. All other authors declare no competing interests.
Similar articles
-
Perceived patient navigator services and characteristics to address barriers to linkage to hepatitis C care among people released from provincial prison in Quebec, Canada.Int J Drug Policy. 2024 Nov;133:104624. doi: 10.1016/j.drugpo.2024.104624. Epub 2024 Oct 18. Int J Drug Policy. 2024. PMID: 39426103
-
Patient and healthcare provider experiences of hepatitis C treatment with direct-acting antivirals in Rwanda: a qualitative exploration of barriers and facilitators.BMC Public Health. 2020 Jun 16;20(1):946. doi: 10.1186/s12889-020-09000-0. BMC Public Health. 2020. PMID: 32546216 Free PMC article.
-
Motivations, facilitators and barriers to accessing hepatitis C treatment among people who inject drugs in two South African cities.Harm Reduct J. 2020 Jun 10;17(1):39. doi: 10.1186/s12954-020-00382-3. Harm Reduct J. 2020. PMID: 32522210 Free PMC article.
-
Using the barriers and facilitators to linkage to HIV care to inform hepatitis C virus (HCV) linkage to care strategies for people released from prison: Findings from a systematic review.J Viral Hepat. 2020 Feb;27(2):205-220. doi: 10.1111/jvh.13220. Epub 2019 Dec 11. J Viral Hepat. 2020. PMID: 31638294
-
Framework for community-based models for treating hepatitis C virus.Aust Health Rev. 2020 Jun;44(3):459-469. doi: 10.1071/AH18220. Aust Health Rev. 2020. PMID: 31671288
Cited by
-
Rapid Treatment Initiation for Hepatitis C Virus Infection: Potential Benefits, Current Limitations, and Real-World Examples.Gastroenterol Hepatol (N Y). 2022 Nov;18(11):628-638. Gastroenterol Hepatol (N Y). 2022. PMID: 36866028 Free PMC article.
-
Integrating Management of Hepatitis C Infection into Primary Care: the Key to Hepatitis C Elimination Efforts.J Gen Intern Med. 2022 Oct;37(13):3435-3443. doi: 10.1007/s11606-022-07628-9. Epub 2022 Apr 28. J Gen Intern Med. 2022. PMID: 35484367 Free PMC article. Review.
-
Inpatient Hepatitis C Treatment Coordination and Initiation for Patients Who Inject Drugs.J Gen Intern Med. 2023 Nov;38(15):3428-3433. doi: 10.1007/s11606-023-08386-y. Epub 2023 Aug 31. J Gen Intern Med. 2023. PMID: 37653211 Free PMC article.
-
Barriers to scaling up hepatitis C treatment in Malaysia: a qualitative study with key stakeholders.BMC Public Health. 2022 Feb 21;22(1):371. doi: 10.1186/s12889-022-12786-w. BMC Public Health. 2022. PMID: 35189876 Free PMC article.
-
Slicing through silos: Development and evaluation of a hospital-based telehealth hepatitis C virus treatment program.Int J Drug Policy. 2024 May;127:104396. doi: 10.1016/j.drugpo.2024.104396. Epub 2024 Apr 9. Int J Drug Policy. 2024. PMID: 38593518 Free PMC article.
References
-
- National Academies of Sciences Engineering and Medicine. A national strategy for the elimination of hepatitis B and C: phase two report [Internet]. Washington DC; 2017 [cited 2019 Sep 27]. Available from: http://www.nationalacademies.org/hmd/reports/2017/national-strategy-for-....
-
- World Health Organization. Hepatitis C [Internet]. [cited 2019 Nov 14]. Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-c.
-
- Jordan AE, Perlman DC, Reed J, Smith DJ, Hagan H. Patterns and gaps identified in a systematic review of the hepatitis C virus care continuum in studies among people who use drugs. Front Public Heal [Internet]. 2017 Dec 18 [cited 2020 Apr 11];5:348. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29326922. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials